Vaccinex, Inc. Accrued Liabilities, Current
Vaccinex, Inc. (VCNX) had Accrued Liabilities, Current of $1.10 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-04-15
- 2024-12-31: Accrued Liabilities, Current $1.10M.
- 2024-09-30: Accrued Liabilities, Current $1.20M.
- 2024-06-30: Accrued Liabilities, Current $1.75M.
- 2024-03-31: Accrued Liabilities, Current $1.88M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-12-31 | $1.10M 10-K · filed 2025-04-15 |
| 2024-09-30 | $1.20M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.75M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.88M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.24M 10-K · filed 2025-04-15 |
| 2023-09-30 | $1.90M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.53M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $975.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $781.00K 10-K/A · filed 2024-04-25 |
| 2022-09-30 | $1.26M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.09M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.01M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $980.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.21M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.50M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.23M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.94M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.99M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.17M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.32M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.67M 10-K · filed 2021-03-31 |
| 2019-09-30 | $4.55M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.05M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.52M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $4.36M 10-K · filed 2020-03-09 |
| 2018-09-30 | $3.82M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $3.84M 10-Q · filed 2018-08-14 |
| 2017-12-31 | $1.96M 10-K · filed 2019-03-13 |